These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 26132825

  • 1. Reactivation of Human Herpes Virus-6 After Pediatric Stem Cell Transplantation: Risk Factors, Onset, Clinical Symptoms and Association With Severity of Acute Graft-Versus-Host Disease.
    Verhoeven DH, Claas EC, Jol-van der Zijde CM, Thijssen JC, Lankester AC, Bredius RG, Putter H, Kroes AC, Egeler RM, Schilham MW, van Tol MJ.
    Pediatr Infect Dis J; 2015 Oct; 34(10):1118-27. PubMed ID: 26132825
    [Abstract] [Full Text] [Related]

  • 2. Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study.
    Dulery R, Salleron J, Dewilde A, Rossignol J, Boyle EM, Gay J, de Berranger E, Coiteux V, Jouet JP, Duhamel A, Yakoub-Agha I.
    Biol Blood Marrow Transplant; 2012 Jul; 18(7):1080-9. PubMed ID: 22212513
    [Abstract] [Full Text] [Related]

  • 3. Human herpesvirus-6 and -7 in pediatric stem cell transplantation.
    Savolainen H, Lautenschlager I, Piiparinen H, Saarinen-Pihkala U, Hovi L, Vettenranta K.
    Pediatr Blood Cancer; 2005 Nov; 45(6):820-5. PubMed ID: 15700258
    [Abstract] [Full Text] [Related]

  • 4. Long-term prognosis of human herpesvirus 6 reactivation following allogeneic hematopoietic stem cell transplantation.
    Iesato K, Hori T, Yoto Y, Yamamoto M, Inazawa N, Kamo K, Ikeda H, Iyama S, Hatakeyama N, Iguchi A, Sugita J, Kobayashi R, Suzuki N, Tsutsumi H.
    Pediatr Int; 2018 Jun; 60(6):547-552. PubMed ID: 29542206
    [Abstract] [Full Text] [Related]

  • 5. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
    de Pagter PJ, Schuurman R, Visscher H, de Vos M, Bierings M, van Loon AM, Uiterwaal CS, van Baarle D, Sanders EA, Boelens J.
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
    [Abstract] [Full Text] [Related]

  • 6. Human Herpes Virus-6 Following Pediatric Allogeneic Hematopoietic Stem Cell Transplantation.
    Shachor-Meyouhas Y, Fesenko A, Kra-Oz Z, Zaidman I, Szwarcwort-Cohen M, Shafran E, Kassis I.
    Isr Med Assoc J; 2015 May; 17(5):302-5. PubMed ID: 26137657
    [Abstract] [Full Text] [Related]

  • 7. High human herpesvirus 6 viral load in pediatric allogeneic hematopoietic stem cell transplant patients is associated with detection in end organs and high mortality.
    Winestone LE, Punn R, Tamaresis JS, Buckingham J, Pinsky BA, Waggoner JJ, Kharbanda S.
    Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29181879
    [Abstract] [Full Text] [Related]

  • 8. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation.
    Wang LR, Dong LJ, Zhang MJ, Lu DP.
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1031-7. PubMed ID: 17067909
    [Abstract] [Full Text] [Related]

  • 9. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation.
    Zerr DM, Corey L, Kim HW, Huang ML, Nguy L, Boeckh M.
    Clin Infect Dis; 2005 Apr 01; 40(7):932-40. PubMed ID: 15824982
    [Abstract] [Full Text] [Related]

  • 10. Low incidence of HHV-6 reactivation in haploidentical hematopoietic stem cell transplantation with corticosteroid as graft-vs-host disease prophylaxis compared with cord blood transplantation.
    Tamaki H, Ikegame K, Yoshihara S, Kaida K, Yoshihara K, Inoue T, Kato R, Nakata J, Fujioka T, Soma T, Okada M, Ogawa H.
    Transpl Infect Dis; 2019 Jun 01; 21(3):e13073. PubMed ID: 30875143
    [Abstract] [Full Text] [Related]

  • 11. The complex relationship between human herpesvirus 6 and acute graft-versus-host disease.
    Pichereau C, Desseaux K, Janin A, Scieux C, Peffault de Latour R, Xhaard A, Robin M, Ribaud P, Agbalika F, Chevret S, Socié G.
    Biol Blood Marrow Transplant; 2012 Jan 01; 18(1):141-4. PubMed ID: 21801705
    [Abstract] [Full Text] [Related]

  • 12. Human herpesvirus 6 reactivation in unmanipulated haploidentical hematopoietic stem cell transplantation predicts the occurrence of grade II to IV acute graft-versus-host disease.
    Han TT, Zhang YN, Sun YQ, Kong J, Wang FR, Wang ZD, Cheng YF, Yan CH, Wang Y, Xu LP, Zhang XH, Liu KY, Huang XJ, Zhao XS.
    Transpl Infect Dis; 2021 Jun 01; 23(3):e13544. PubMed ID: 33326670
    [Abstract] [Full Text] [Related]

  • 13. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
    Gotoh M, Yoshizawa S, Katagiri S, Suguro T, Asano M, Kitahara T, Akahane D, Okabe S, Tauchi T, Ito Y, Ohyashiki K.
    Transpl Infect Dis; 2014 Jun 01; 16(3):440-9. PubMed ID: 24810656
    [Abstract] [Full Text] [Related]

  • 14. Human herpesvirus 6 in biopsies from patients with gastrointestinal symptoms after allogeneic stem cell transplantation.
    Mousset S, Martin H, Berger A, Heß S, Bug G, Kriener S, Engels K, Hoelzer D, Klein SA.
    Ann Hematol; 2012 May 01; 91(5):737-742. PubMed ID: 22048789
    [Abstract] [Full Text] [Related]

  • 15. Risk factors and clinical consequences of human herpesvirus 7 infection in paediatric haematopoietic stem cell transplant recipients.
    Chan PK, Li CK, Chik KW, Lee V, Shing MM, Ng KC, Cheung JL, Fok TF, Cheng AF.
    J Med Virol; 2004 Apr 01; 72(4):668-74. PubMed ID: 14981771
    [Abstract] [Full Text] [Related]

  • 16. Analysis of the shedding of three β-herpesviruses DNA in Polish patients subjected to allogeneic hematopoietic stem cell transplantation: Six-year follow up.
    Dzieciatkowski T, Tomaszewska A, Przybylski M, Rusicka P, Basak GW, Jedrzejczak WW, Wroblewska M, Halaburda K.
    J Clin Virol; 2016 Mar 01; 76():30-5. PubMed ID: 26809130
    [Abstract] [Full Text] [Related]

  • 17. Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation.
    Tokimasa S, Hara J, Osugi Y, Ohta H, Matsuda Y, Fujisaki H, Sawada A, Kim JY, Sashihara J, Amou K, Miyagawa H, Tanaka-Taya K, Yamanishi K, Okada S.
    Bone Marrow Transplant; 2002 Apr 01; 29(7):595-8. PubMed ID: 11979309
    [Abstract] [Full Text] [Related]

  • 18. Impact of Human Herpesvirus-6 Reactivation on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation.
    Aoki J, Numata A, Yamamoto E, Fujii E, Tanaka M, Kanamori H.
    Biol Blood Marrow Transplant; 2015 Nov 01; 21(11):2017-22. PubMed ID: 26226409
    [Abstract] [Full Text] [Related]

  • 19. Infections with human herpesvirus 6 variant B delay platelet engraftment after allogeneic haematopoietic stem cell transplantation.
    Radonić A, Oswald O, Thulke S, Brockhaus N, Nitsche A, Siegert W, Schetelig J.
    Br J Haematol; 2005 Nov 01; 131(4):480-2. PubMed ID: 16281938
    [Abstract] [Full Text] [Related]

  • 20. Relationship among human herpesvirus 6 reactivation, serum interleukin 10 levels, and rash/graft-versus-host disease after allogeneic stem cell transplantation.
    Kitamura K, Asada H, Iida H, Fukumoto T, Kobayashi N, Niizeki H, Morii T, Kimura H, Miyagawa S.
    J Am Acad Dermatol; 2008 May 01; 58(5):802-9. PubMed ID: 18367292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.